We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Hepatitis C virus (HCV) protease variability and anti-HCV protease inhibitor resistance in HIV/HCV-coinfected patients.
- Authors
Trimoulet, P.; Belzunce, C.; Faure, M.; Wittkop, L.; Reigadas, S.; Dupon, M.; Ragnaud, J.-M.; Fleury, H.; Neau, D.
- Abstract
Objectives Data on the natural selection of isolates harbouring mutations within the NS3 protease, conferring resistance to hepatitis C virus (HCV) protease inhibitors (PIs), are limited for HIV/HCV-coinfected patients. The aim of this study was to describe the natural prevalence of mutations conferring resistance to HCV PIs in HIV/HCV-coinfected patients compared with HCV-monoinfected patients. Methods The natural prevalences of HCV PI resistance mutations in 120 sequences from HIV/HCV-coinfected patients (58 genotype 1a, 18 genotype 1b and 44 genotype 4) and 501 sequences from HCV-monoinfected patients (476 genotype 1 and 25 genotype 4), retrieved from GenBank as a control group, were compared. Results Of 76 sequences from HIV/HCV genotype 1-coinfected patients, six (7.9%) showed amino acid substitutions associated with HCV PI resistance (V36L, n=1; V36M, n=2; T54S, n=2; R155K, n=1). In 31 of 476 (6.5%) HCV genotype 1 sequences retrieved from the GenBank database, HCV PI resistance mutations were found. The difference was not statistically significant ( P=0.6). All of the sequences from HIV/HCV genotype 4-coinfected patients and those retrieved from the GenBank database had amino acid changes at position 36 (V36L). Conclusion Our study suggests that the natural prevalence of strains resistant to HCV PIs does not differ between HCV-monoinfected and HIV/HCV-coinfected patients. Further studies on larger cohorts are needed to confirm these findings and to evaluate the impact of these mutations in clinical practice.
- Subjects
RNA physiology; DRUG resistance; GENES; HEPATITIS C; HIV-positive persons; GENETIC mutation; POLYMERASE chain reaction; DATA analysis; PROTEASE inhibitors
- Publication
HIV Medicine, 2011, Vol 12, Issue 8, p506
- ISSN
1464-2662
- Publication type
Article
- DOI
10.1111/j.1468-1293.2011.00913.x